{
  "slug": "ag1-ritual-blueland-2026-09-08t03-3",
  "company": "AG1, Ritual, Blueland",
  "headline": "Clinical research becomes growth engine; brands fund studies to prove efficacy.",
  "topic": "{Stash Edge — Brand-Story Play}",
  "source_name": "Modern Retail",
  "source_url": "https://www.modernretail.co/operations/how-clinical-research-is-being-used-as-a-growth-engine/?utm_campaign=modernretaildis&utm_medium=rss&utm_source=general-rss",
  "landing": "https://pops4-stash-edge.billing-010.workers.dev/articles/ag1-ritual-blueland-2026-09-08t03-3",
  "channels": {
    "linkedin": {
      "label": "LinkedIn · Jenny",
      "body": "{Stash Edge — Brand-Story Play}\n◆ GOLD · Third-party validation through clinical trials · AG1, Ritual, Blueland\n\nClinical research becomes growth engine; brands fund studies to prove efficacy.\n\nMost brands skip the research because the bill is steep. These three paid it. Now they own the claim. A competitor can copy their formula, but they can't copy the study. Clinical validation is the only form of proof that actually ages—the older the research, the more credible it becomes. This is expensive positioning, which means it's rare, which means it works.\n\nMy Stash Take on what it means for the rest of us →\nhttps://pops4-stash-edge.billing-010.workers.dev/l/t/li/ag1-ritual-blueland-2026-09-08t03-3\n→ Your Stash Room — your logo, live pricing, ships blind: https://pops4-stash-edge.billing-010.workers.dev/l/r/li/ag1-ritual-blueland-2026-09-08t03-3\n→ Proper imprints, done right at POPS4: https://pops4-stash-edge.billing-010.workers.dev/l/s/li/ag1-ritual-blueland-2026-09-08t03-3",
      "chars": 985,
      "limit": 3000,
      "alt_label": "HakoShikin agency",
      "alt_body": "{Stash Edge — Brand-Story Play}\n◆ GOLD · Third-party validation through clinical trials · AG1, Ritual, Blueland\n\nClinical research becomes growth engine; brands fund studies to prove efficacy.\n\nMost brands skip the research because the bill is steep. These three paid it. Now they own the claim. A competitor can copy their formula, but they can't copy the study. Clinical validation is the only form of proof that actually ages—the older the research, the more credible it becomes. This is expensive positioning, which means it's rare, which means it works.\n\nMy Stash Take on what it means for the rest of us →\nhttps://pops4-stash-edge.billing-010.workers.dev/l/t/lh/ag1-ritual-blueland-2026-09-08t03-3\n→ Your Stash Room — your logo, live pricing, ships blind: https://pops4-stash-edge.billing-010.workers.dev/l/r/lh/ag1-ritual-blueland-2026-09-08t03-3\n→ Proper imprints, done right at POPS4: https://pops4-stash-edge.billing-010.workers.dev/l/s/lh/ag1-ritual-blueland-2026-09-08t03-3",
      "alt_chars": 985,
      "alt_limit": 3000
    },
    "bluesky": {
      "label": "Bluesky",
      "body": "{Stash Edge — Brand-Story Play}\n◆ GOLD · Third-party validation through clinical trials · AG1, Ritual, Blueland\n\nClinical research becomes growth engine; brands fund studies to prove…\n\nMy Stash Take →\nhttps://pops4-stash-edge.billing-010.workers.dev/l/t/bs/ag1-ritual-blueland-2026-09-08t03-3",
      "chars": 292,
      "limit": 300
    },
    "substack": {
      "label": "Substack · Fending",
      "title": "Clinical research becomes growth engine; brands fund studies to prove efficacy.",
      "body": "✍️ YOUR NOTE — write 2–3 lines to ONE person so they feel: \"this is about me… I could actually do this… I could make money from this.\" Energize them, make it yours. (This is the part that gets the opens.)\n[ your take… ]\n———\nHere is a real one you can run this week 👇\nCompanies like AG1, Ritual, and Blueland are investing in clinical research as a way to fuel brand growth and establish credibility, per Modern Retail.\nHere's the cool part — the lever almost everyone misses (and you don't have to): clinical validation is the highest-trust asset a CPG brand can own. Instead of claiming a benefit, run a study, publish it, and cite it for the next three years. The upfront cost is real, but the payoff is a permanently defensible claim. Once you have a peer-reviewed study, every competitor who makes the same claim without research appears weak. Use clinical proof as your long-term content and positioning engine, not as a one-time press release.\nWhat that means for you: Most brands skip the research because the bill is steep. These three paid it. Now they own the claim. A competitor can copy their formula, but they can't copy the study. Clinical validation is the only form of proof that actually ages—the older the research, the more credible it becomes. This is expensive positioning, which means it's rare, which means it works.\nIf you make, sell, or gift anything with your name on it — this is yours to run. You can do this.\n(Real, not theory — Modern Retail: https://www.modernretail.co/operations/how-clinical-research-is-being-used-as-a-growth-engine/?utm_campaign=modernretaildis&utm_medium=rss&utm_source=general-rss.)\n———\nOr — want it built FOR you? Your logo, your products, your own private room, priced and ready, in about five minutes. That's literally what we do →\nhttps://www.pops4.com/vip?utm_source=substack&utm_medium=newsletter&utm_campaign=stash",
      "chars": 1876,
      "limit": 0
    }
  }
}